Menu Back to Improving-Efficiency-Within-the-Current-Regulatory-System-Results-of-the-Escher-project

Program Committee

  • Peter  Bachmann, DrSc, PhD
    Peter Bachmann, DrSc, PhD Senior Expert, European Drug and Regulatory and International Affairs
    Federal Institute for Drugs and Medical Devices (BfArM), Germany
  • Andre  Broekmans
    Andre Broekmans Director, Escher
    TI Pharma, Netherlands
  • Jean Philippe  de Jong, DrMed, MD, PhD, MA, MSc
    Jean Philippe de Jong, DrMed, MD, PhD, MA, MSc Project Leader, Exon Consultancy
    The Escher Project, Netherlands
  • Angelika  Joos, MPharm
    Angelika Joos, MPharm Executive Director, Global Regulatory Policy
    MSD (Europe) Inc., Belgium
  • Susan M Sandler
    Susan M Sandler Senior Director, Regulatory Affairs, Clinical Research Services
    PAREXEL International, United Kingdom
  • Davina Elizabeth Stevenson, PhD
    Davina Elizabeth Stevenson, PhD Associate Director, Regulatory Affairs
    Gilead Sciences International Ltd, United Kingdom
Load More